VivoSim Labs, Inc. Contract Liability (Deferred Revenue)
VivoSim Labs, Inc. (VIVS) had Contract Liability (Deferred Revenue) of $0 as of 2020-12-31, per its 10-Q filed 2021-02-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-02-08
- 2020-12-31: Contract with Customer, Liability, Current $0.00.
- 2020-09-30: Contract with Customer, Liability, Current $0.00.
- 2020-06-30: Contract with Customer, Liability, Current $0.00.
- 2020-03-31: Contract with Customer, Liability, Current $0.00.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-12-31 | $0.00 10-Q · filed 2021-02-08 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $0.00 10-Q · filed 2021-02-08 |
| 2019-12-31 | $0.00 10-Q · filed 2020-02-10 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $532.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $525.00K 10-K · filed 2020-05-28 |
| 2018-12-31 | $580.00K 10-Q · filed 2019-02-07 |
| 2018-09-30 | $619.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $628.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $668.00K 10-K · filed 2019-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |